Despite reporting positive Phase II results for its lead candidate last year, Vaccinex will soon no longer be a publicly ...

The financial results for Anteris for the year ended December 31, 2024 are reviewed below. All amounts in $ refer to U.S. dollars. In 2024, Net Sales were $2.7 million relating to sales of our tissue ...

Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed ...

China clamps down on small-cap U.S. listings by Chinese issuers; China mandates personal information protection compliance ...

For Israeli tech companies with global ambitions, the choice of public market can shape their growth trajectory.

Chinese tea-drink maker Chagee Holdings has secured approval from the country's market regulator for an initial public offering (IPO) in the US, just days after competing chain Mixue made its ...

Division of Corporation Finance announced that it has expanded its confidential filing process for certain draft registration statements submitted for nonpublic review. Since 2012, many issuers have ...

Good day, and welcome to BingEx 2024 fourth-quarter and full-year financial results conference call. Today's conference is being recorded. At this time, I'd like to turn the conference over to Helen ...

Marex Group PLC (MRX) reports a 40% increase in adjusted profit before tax and a 28% revenue growth, showcasing robust financial health and strategic expansion.

Confluent's stock has performed well recently, fundamental business issues persist, including weak customer growth and a ...

Research and development expenses were $21.8 million for the quarter ended December 31, 2024, compared to $11.6 million for ...

We recently published a list of 10 Stocks With At Least $20 Million In Insider Spending Recently. In this article, we are ...